Newsroom

In This Section

News Release

Mallinckrodt Presents Data on Real-World Outcomes with Acthar® Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)

Print Page | RSS Feeds | Email Alerts

Building On Our Heritage

More than 150 years of quality, integrity and service.

Learn More

Join Us

Invest in your own career with Mallinckrodt and let’s do something dynamic together..

Learn How